Schizophrenia and schizoaffective disorders are severe mental conditions characterized by hallucinations, delusions, and mood disturbances. The Journal of Clinical Psychiatry offers a deep dive into these disorders, emphasizing their diagnosis, management, and underlying causes. Our expert editors ensure content is both clinically relevant and actionable, aiding psychiatrists in offering effective and compassionate care.
Schizophrenia and Schizoaffective Disorders
Page 29
Recently published articles about Schizophrenia/Schizoaffective Disorders
Letter to the Editor
Clinical Correlates of oGTT Performance in Olanzapine-Treated Patients
December 28, 2016
Olanzapine is associated with glucoregulatory abnormalities, but the underlying mechanisms remain unclear. Guina et al looked at oral glucose tolerance test performance in 35 patients treated with olanzapine to...
Clinical and Practical Psychopharmacology
Comparing Efficacy of Antipsychotic Drugs in Schizophrenia
December 28, 2016
How do antipsychotics compare to one another in terms of efficacy? Which ones are particularly effective for treatment-resistant patients? In this month's column, Dr Andrade considers the findings of...
Original Research
Antipsychotic Maintenance Treatment for Schizophrenia
November 23, 2016
Several antipsychotics have shown efficacy for schizophrenia in controlled settings, but how effective are they in the long-term treatment of individuals in community settings? Learn how 7 antipsychotics compared...
Article
Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients Who Did Not Respond to a Modest Dosage: A Double-Blind Randomized Controlled Trial
October 26, 2016
When your patients with schizophrenia insufficiently respond to antipsychotic treatment, do you increase the dose? Do you check their plasma drug concentration? Read this CME article to find out...
